Sartan-induced interstitial lung disease.

Area of Science:

• Pharmacology
• Pulmonology
• Toxicology

Background:

• Angiotensin receptor blockers (sartans) are widely prescribed medications.
• Lung toxicity associated with sartans is rarely documented in medical literature.
• This study focuses on a unique case of sartan-induced lung disease.

Observation:

• A 60-year-old male experienced interstitial lung disease symptoms, including dyspnea and hemoptysis, attributed to eprosartan in 2012.
• Symptoms resolved completely upon discontinuation of eprosartan.
• Ten years later, the patient developed similar symptoms and radiographic findings after initiating valsartan, another sartan.

Findings:

• The patient experienced two distinct episodes of drug-induced interstitial lung disease.
• Both episodes were linked to different sartans (eprosartan and valsartan).
• The clinical presentation and chest CT imaging were comparable between the two events.

Implications:

• This case highlights the potential for sartans to cause interstitial lung disease.
• It suggests that patients may react to multiple drugs within the sartan class.
• Further investigation into sartan-induced lung toxicity is warranted.